A detailed history of Reitz Capital Advisors LLC transactions in Zomedica Corp. stock. As of the latest transaction made, Reitz Capital Advisors LLC holds 23,000 shares of ZOM stock, worth $2,760. This represents 0.01% of its overall portfolio holdings.

Number of Shares
23,000
Previous 23,000 -0.0%
Holding current value
$2,760
Previous $4,000 25.0%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 18, 2023

BUY
$0.16 - $0.25 $80 - $125
500 Added 2.22%
23,000 $4,000
Q3 2022

Oct 27, 2022

BUY
$0.2 - $0.38 $1,500 - $2,850
7,500 Added 50.0%
22,500 $5,000
Q1 2022

Apr 14, 2022

SELL
$0.28 - $0.4 $126 - $180
-450 Reduced 2.91%
15,000 $5,000
Q4 2021

Jan 20, 2022

BUY
$0.31 - $0.58 $635 - $1,189
2,050 Added 15.3%
15,450 $13,000
Q3 2021

Oct 18, 2021

SELL
$0.46 - $0.81 $943 - $1,660
-2,050 Reduced 13.27%
13,400 $7,000
Q2 2021

Jul 15, 2021

BUY
$0.72 - $1.46 $11,124 - $22,557
15,450 New
15,450 $13,000

Others Institutions Holding ZOM

About Zomedica Corp.


  • Ticker ZOM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 979,950,016
  • Market Cap $118M
  • Description
  • Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...
More about ZOM
Track This Portfolio

Track Reitz Capital Advisors LLC Portfolio

Follow Reitz Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reitz Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reitz Capital Advisors LLC with notifications on news.